P. Orezzi
Impact in
- Toxicology top 2%
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
Papers in
-
- Cancer therapeutics and mechanisms 5
- DNA and Nucleic Acid Chemistry 2
-
- Synthesis and Reactions of Organic Compounds 3
- Synthesis and Biological Evaluation 2
- Co-authors
- Federico Arcamone (6 shared papers)Giuseppe Cassinelli (8 shared papers)A. Grein (3 shared papers)C. Spalla (2 shared papers)G. FRANCESCHI (5 shared papers)Rosanna Mondelli (2 shared papers)Silvana Penco (1 shared paper)M. Gaetani (2 shared papers)
- Journals
- Tetrahedron Letters (2 papers)Biotechnology and Bioengineering (2 papers)Nature (2 papers)Journal of the American Chemical Society (2 papers)Cellular and Molecular Life Sciences (2 papers)
- Partner nations
- ItalyMalaysiaSwitzerland
In The Last Decade
P. Orezzi
14 papers receiving 1.3k citations
P. Orezzi's Hit Papers
Peers
Comparison fields: 5 of 93
- Toxicology 84
- Pharmacology 292
- Oncology 431
- Organic Chemistry 469
- Cardiology and Cardiovascular Medicine 249
Countries citing papers authored by P. Orezzi
This map shows the geographic impact of P. Orezzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Orezzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Orezzi more than expected).
Fields of papers citing papers by P. Orezzi
This network shows the impact of papers produced by P. Orezzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Orezzi. The network helps show where P. Orezzi may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Orezzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesius Hit paper breakdown → | 1969 | 531 |
| 2 | 1964 | 209 | |
| 3 | 1964 | 190 | |
| 4 | 1964 | 140 | |
| 5 | 1964 | 108 | |
| 6 | 1968 | 60 | |
| 7 | 2000 | 56 | |
| 8 | 1968 | 41 | |
| 9 | 1967 | 38 | |
| 10 | Experimental studies on distamycin A--a new antibiotic with cytotoxic activity. | 1962 | 21 |
| 11 | 1972 | 18 | |
| 12 | 1992 | 15 | |
| 13 | 1988 | 14 | |
| 14 | 1968 | 8 |
About P. Orezzi
P. Orezzi is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Cancer Research and Small Animals, having authored 14 papers that have together received 1.4k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (6 papers), Cancer therapeutics and mechanisms (5 papers), Synthesis and Biological Activity (4 papers), Synthesis and Reactions of Organic Compounds (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), DNA and Nucleic Acid Chemistry (2 papers), Infectious Diseases and Mycology (2 papers) and Synthesis and Biological Evaluation (2 papers). The work is most often cited by research in Toxicology (84 citations), Pharmacology (292 citations), Oncology (431 citations), Organic Chemistry (469 citations) and Cardiology and Cardiovascular Medicine (249 citations). P. Orezzi has collaborated with scholars based in Italy, Malaysia and Switzerland. Frequent co-authors include Federico Arcamone, Giuseppe Cassinelli, A. Grein, C. Spalla, G. FRANCESCHI, Rosanna Mondelli, Silvana Penco, M. Gaetani, Rosella Silvestrini and Laura Grazia Valentini. Their work appears in journals such as Tetrahedron Letters, Biotechnology and Bioengineering, Nature, Journal of the American Chemical Society and Cellular and Molecular Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.